small-cap

Is Prospa Group Limited in Buy Zone- PGL

Dec 30, 2019 | Team Kalkine
Is Prospa Group Limited in Buy Zone- PGL

Prospa Group Limited


PGL Details

Introduction of New Junior Funding Partner: Prospa Group Limited (ASX: PGL) is involved in the provisioning of finance to small businesses. The market capitalisation of the company stood at A$287.2 Mn as on 27th December 2019. Recently, the company announced that it has introduced a new Junior Funding Partner into one of its Australian Warehouse Facilities, which finances small business loans as well as a line of credit facilities. The company also mentioned that the facility has been designed to seamlessly scale up over time as PGL continues to expand its Australian operations and has an initial capacity of A$20 Mn. Junior Funding Partner has subscribed to Class B Notes in the warehouse facility and the transaction releases a capital amounting to $17.8 million. This transaction reflects an important part of the long-term capital management strategy of the company.

In another update, the company notified the market participants that it has been added to the lender panel of PLAN Australia and onboarding of the same is anticipated to begin in mid-to-late January 2020. When it comes to the performance of the financial year 2019, the company has launched its business in New Zealand and brought two new products to the market. The company reported continued momentum as well as strong demand, with originated loan volume amounting to $501.7 million, reflecting a rise of 36.6% as compared to the previous year. At the end of FY19, the company possessed a cash balance of ~$70 million to finance investment in the small business loan product in addition to the new initiatives in New Zealand, Line of Credit as well as ProspaPay. The following picture provides an idea of the funding capacity:


Funding Capacity (Source: Company Reports)

Expectation of Rise in Total Originations: For 2020, the company is anticipating total originations in the ambit of $626 Mn to $640 Mn, reflecting a rise in the range of 25% and 28% as compared to FY19. The company is expecting revenue to be at least $150 million in FY20. The company is planning to continue acceleration in the New Zealand market in order to secure market leadership. PGL is also planning to maintain its market leadership in the small business loan product in Australia and to continue to refine the best-in-class credit decision engine as well as data insights capability. The company will continue to make investments in the brand, customer acquisition as well as distribution partner marketing.

Stock Recommendation: Prospa Group Limited is planning to maintain focus on premiumisation of its portfolio and will continue to leverage the strength of its funding platform. The company is anticipating growth on the back of investment in new solutions like Line of Credit, ProspaPay and Mobile App. The business of the company happens to be strong, fast-growing with a continued commitment to putting the small business customers first. The company currently possesses a balance sheet, which is well placed for growth. Current ratio of the company stood at 12.17x in FY19 as compared to 6.37x in FY18. This reflects that the company is in a better position to address its short-term obligations. On the valuation side, the stock is available at EV to Sales multiple of 2.2x in comparison to the industry median (Banking Services) of 3.2x on TTM basis.  As per ASX, the stock of PGL is trading close to its 52-week low of A$1.650. In light of the decent liquidity position and balance sheet, and total origination guidance, we give a “Speculative Buy” recommendation on the stock at the current market price of $1.880 per share, up 5.618% on 27th December 2019.

 
PGL Daily Technical Chart (Source: Thomson Reuters)


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Past performance is not a reliable indicator of future performance.